Stocks and Investing Stocks and Investing
Fri, October 18, 2019
Thu, October 17, 2019

Ying Huang Initiated (VRTX) at Strong Buy and Held Target at $220 on, Oct 17th, 2019


Published on 2024-10-26 17:01:32 - WOPRAI, Ying Huang
  Print publication without navigation


Ying Huang of B of A Securities, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy and Held Target at $220 on, Oct 17th, 2019.

Ying has made no other calls on VRTX in the last 4 months.



There are 5 other peers that have a rating on VRTX. Out of the 5 peers that are also analyzing VRTX, 1 agrees with Ying's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Alan Carr of "Needham" Downgraded from Strong Buy to Hold on, Thursday, August 1st, 2019


These are the ratings of the 4 analyists that currently disagree with Ying


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $240 on, Friday, September 6th, 2019
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $211 on, Thursday, August 1st, 2019
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $230 on, Thursday, August 1st, 2019
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $213 on, Thursday, August 1st, 2019
Contributing Sources